ZA738595B - W-pentanorprostaglandins - Google Patents

W-pentanorprostaglandins

Info

Publication number
ZA738595B
ZA738595B ZA738595A ZA738595A ZA738595B ZA 738595 B ZA738595 B ZA 738595B ZA 738595 A ZA738595 A ZA 738595A ZA 738595 A ZA738595 A ZA 738595A ZA 738595 B ZA738595 B ZA 738595B
Authority
ZA
South Africa
Prior art keywords
pentanorprostaglandins
Prior art date
Application number
ZA738595A
Other languages
English (en)
Inventor
H Hess
T Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA738595B publication Critical patent/ZA738595B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA738595A 1972-11-08 1973-11-08 W-pentanorprostaglandins ZA738595B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
ZA738595B true ZA738595B (en) 1974-09-25

Family

ID=23177829

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA738595A ZA738595B (en) 1972-11-08 1973-11-08 W-pentanorprostaglandins

Country Status (20)

Country Link
JP (1) JPS5714347B2 (da)
AT (1) AT345999B (da)
BE (1) BE807046A (da)
CA (1) CA1033727A (da)
CH (1) CH593930A5 (da)
DE (1) DE2355731C3 (da)
DK (1) DK143499C (da)
ES (3) ES420386A1 (da)
FI (1) FI58912C (da)
FR (3) FR2205338B1 (da)
GB (1) GB1456838A (da)
IE (1) IE40043B1 (da)
IL (2) IL50310A (da)
IN (1) IN139265B (da)
NL (1) NL7315307A (da)
NO (2) NO143663C (da)
PH (2) PH13261A (da)
SE (4) SE412229B (da)
SU (2) SU667131A3 (da)
ZA (1) ZA738595B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (de) * 1977-12-03 1979-06-07 Bayer Ag Neue bicycloalkenyl-prostaglandine und verfahren zu ihrer herstellung
TR200000671T2 (tr) * 1997-09-09 2000-07-21 The Procter & Gamble Company FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
SK3362000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound analogous to prostaglandin f and use thereof
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
DE502007000840D1 (de) * 2007-11-28 2009-07-16 Bauer Maschinen Gmbh Winde
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (da) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
ES444398A1 (es) 1977-12-01
FR2205338B1 (da) 1978-07-13
FI58912B (fi) 1981-01-30
FR2286147A1 (fr) 1976-04-23
FR2205338A1 (da) 1974-05-31
CA1033727A (en) 1978-06-27
IN139265B (da) 1976-05-29
AU6230273A (en) 1975-05-08
NO143663C (no) 1981-03-25
NO144385C (no) 1981-08-19
IE40043B1 (en) 1979-02-28
SE7612262L (sv) 1976-11-03
CH593930A5 (da) 1977-12-30
IL43571A0 (en) 1974-03-14
DE2355731B2 (de) 1980-04-30
JPS49133357A (da) 1974-12-21
PH13320A (en) 1980-03-13
SU667131A3 (ru) 1979-06-05
PH13261A (en) 1980-02-25
ES456279A1 (es) 1978-11-01
FR2286147B1 (da) 1978-09-22
SE417957B (sv) 1981-04-27
IL50310A (en) 1977-08-31
BE807046A (fr) 1974-05-08
NO743616L (no) 1974-05-09
FR2291200B1 (da) 1979-01-05
IL43571A (en) 1977-08-31
NO144385B (no) 1981-05-11
FR2291200A1 (fr) 1976-06-11
DK143499B (da) 1981-08-31
AT345999B (de) 1978-10-10
NO143663B (no) 1980-12-15
FI58912C (fi) 1981-05-11
DE2355731C3 (de) 1981-01-15
SE7612261L (sv) 1976-11-03
ES420386A1 (es) 1976-07-01
DK143499C (da) 1982-01-11
IE40043L (en) 1974-05-08
DE2355731A1 (de) 1974-05-22
SE412229B (sv) 1980-02-25
SE7701523L (sv) 1977-02-10
SU704456A3 (ru) 1979-12-15
GB1456838A (en) 1976-11-24
NL7315307A (da) 1974-05-10
ATA941073A (de) 1978-02-15
JPS5714347B2 (da) 1982-03-24

Similar Documents

Publication Publication Date Title
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
ZA738595B (en) W-pentanorprostaglandins
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU5993373A (en) N-sulphenylated carbamidoximes
AU6362373A (en) N-propargylacetanilide herbicedes
GB1402226A (en) 3-cyanochromones
GB1401579A (en) Indolo-quinolizines
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
HK45678A (en) Imino-isoindolinones
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
AU6332973A (en) Bulbholders
AU5233473A (en) Nitro-imidazolyl-pyrimidines
GB1401735A (en) Imino-lactams
AU5191873A (en) Benzylpyrimidines
GB1405254A (en) Bis- substituted-henoxy- propanes
GB1400667A (en) 4-spirocyclopropyl-androstenes
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1415691A (en) Bracks
GB1402045A (en) 11-o-methanesulphonylerythromycins
HK10479A (en) Weatherbar
AU5900173A (en) Thiazolopyrimidines
GB1368732A (en) Trans-polyalkenamers